What Are the Key Market Sizes and Growth Forecasts for the Global Cancer Biomarker Market?
The Cancer Biomarker Market size has grown significantly in the recent past, jumping from $22.19 billion in 2024 to an estimated $25.28 billion in 2025, progressing at a compound annual growth rate (CAGR) of 13.9%. Growth in the historical period has been largely driven by a shift towards personalized medicine, advancements in immunotherapy, changes in regulatory framework, collaborative research efforts, and a focus on non-coding RNAs.
The market size is poised for further rapid growth, expected to reach $45.88 billion by 2029, with a CAGR of 16.1%. The forecast growth can be attributed to a shift towards patient-Centric diagnostics, integration of biomarkers in clinical trials, emergence of multiplex biomarker panels, further exploration of non-coding RNAs, and commercialization of biomarker tests. Forefront trends expected to shape the market include advancements in genomics, precision medicine approaches, liquid biopsies, improvements in immunotherapy, and integration of artificial intelligence (AI).
Get Your Free Sample of The Global Cancer Biomarker Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8492&type=smp
What Are the Core Factors Driving the Global Cancer Biomarker Market?
The increasing incidence of cancer has been a key driver for the growth of the cancer biomarker market. This increase has triggered a widespread use of cancer biomarkers as they are beneficial in assessing disease risk, screening for potential primary tumors, distinguishing benign from malignant indicators, and differentiating one form of malignancy from another. Recent research by the American Cancer Society estimates 609,360 cancer deaths and 1.9 million new cancer cases in the US alone for 2022. This escalation in cancer incidence rates is expected to continue as a major factor propelling growth of the cancer biomarker market.
Which Are the Major Segments in the Global Cancer Biomarker Market?
The cancer biomarker market is further segmented into:
1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Who Are the Major Players in the Global Cancer Biomarker Market?
Major players operating in the cancer biomarker market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.
What Are the Emerging Trends in the Global Cancer Biomarker Market?
Major companies in the cancer biomarker market continue to focus on developing innovative solutions such as AI-powered cancer biomarkers, designed to enhance diagnostic accuracy and tailor treatment plans for individual patients. For instance, in 2023, Ibex Medical Analytics, a US firm, launched an AI solution called Galen Breast HER2, aimed at enhancing HER2 scoring accuracy in breast cancer patients.
Which Region is Poised for the Fastest Growth in the Cancer Biomarker Market?
In 2024, North America was the largest regional market for cancer biomarkers. However, Asia-Pacific is forecasted to be the fastest-growing region over the next few years. The Cancer Biomarker Market research extends across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does the Cancer Biomarker Market Report 2025 Offer?
A cancer biomarker refers to a biological molecule found in blood, tissues, or other bodily fluids that signifies normal or abnormal activity, or a condition or disease. These biomarkers are used to understand changes in the tumor. The Cancer Biomarker Market research report from The Business Research Company provides global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8492
About The Business Research Company
Our company, armed with over 15000+ reports from 27 industries covering 60+ geographical regions, has built a reputation for offering comprehensive and data-rich research and insights. With 1,500,000 datasets, we aim to provide the data you need to stay ahead through our in-depth secondary research and unique insights from industry leaders.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
